News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Synta Pharmaceuticals Sets IPO At 6 Million Shares, $14-$16 Each
January 23, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Jan 23 (Reuters) - Synta Pharmaceuticals Corp. on Tuesday set its planned initial public offering at 6 million shares for an estimated price of $14 to $16 each.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
IPO tracker
Avalyn seeks public debut to support new lung drug formulations
April 24, 2026
·
11 min read
·
Editorial Team
Deals
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
April 23, 2026
·
2 min read
·
Nick Paul Taylor
Podcast
Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win
April 22, 2026
·
1 min read
·
Heather McKenzie
Series A
Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs
April 21, 2026
·
1 min read
·
Gabrielle Masson
